Walking you through the new funding deal, the December decision point on enhanced ACA credits, and the latest federal, state, and industry moves in the health policy arena.
Hearing recap covers cost savings, reduced hospital days, and how local aging networks keep people at home and connected.
Shutdown drama, delayed hearings, obesity drugs, rural health, and a faster path for biosimilars lead the week.
Advanced/continuous manufacturing, risk-based inspections, and the capital barriers policy can solve.
The shutdown continues but the to do list grows with SNAP relief, ACA subsidy extensions, 340B reforms, and agency staffing all poised to shift
Senate Aging Committee reviews market competition in hospital pricing, transparency bundles, TRICARE pharmacy practices, and more.
The government is at a standstill as ACA mandates, subsidies, and market rules dominate discourse. Here's what you need to know going into the week.
Congress wrestles over a health-care rider as 100% drug duties near, putting costs, coverage, and supply chains on edge.
Proposals to align FDA and CMS decisions, speed evidence development, and reduce multi-year access bottlenecks.
Senate Aging Committee talks China/India dependencies, shortage math, and real market levers.
Witnesses described political sign-offs on science, late or missing data, and a vaccine panel reset that may reshape childhood schedules.
HHS cuts advance, drug-ad risks go bold, states protect school vaccines. Here are the health policy updates you need going into the week.
